| Efficacy and Safety of Tixel Treatment on Facial and/or Scalp Actinic Keratoses. (NCT05365386) | Novoxel Ltd. | 2022-05-17 |
| Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis (NCT05202860) | Merete Haedersdal | 2022-05-09 |
| Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis (NCT05078827) | Encube Ethicals Pvt. Ltd. | 2022-03-01 |
| Comparison of Nicotinamide Treatments for Actinic Keratosis (NCT07049068) | Federal University of Rio Grande do Sul | 2022-02-01 |
| Clinical Evaluation of a Short Illumination Duration (35 Minutes) When Performing PDT of AK Using the Dermaris ® (NCT05522036) | Centre Dermatologique du Roy | 2022-01-01 |
| Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo (NCT04969419) | Momentum Data | 2021-06-18 |
| Comparing Immune Responses to Topical Imiquimod (NCT04809662) | University of California, Davis | 2021-03-16 |
| High- and Low-risk Actinic Keratosis Referrals to Secondary Care (NCT05976061) | Maastricht University Medical Center | 2021-03-01 |
| Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial (NCT04875026) | Pierre Fabre Medicament | 2021-02-16 |
| The Influence of an E-learning Program on Recognition of Actinic Keratosis (NCT05987553) | Maastricht University Medical Center | 2021-01-01 |
| HRQoL Keratinocyte Carcinomas (NCT04814953) | University Hospital, Ghent | 2020-07-01 |
| Evaluation of The Efficacy and Safety of Tixel Treatment for the Treatment of Facial and/or Scalp Actinic Keratoses (NCT04527653) | Novoxel Ltd. | 2020-05-14 |
| Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK) (NCT04319159) | Biofrontera Bioscience GmbH | 2020-03-05 |
| Implementation of Actinic Keratosis Guideline Among General Practitioners. (NCT05976048) | Maastricht University Medical Center | 2020-03-01 |
| Duration of Ameluz Application in Acral Actinic Keratoses Response (NCT03963102) | Royal Cornwall Hospitals Trust | 2019-10-30 |
| Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face (NCT04085367) | Galderma R&D | 2019-09-30 |
| Combination Topical Therapy for Treatment of Scalp Actinic Keratoses (NCT03996252) | Tulane University | 2019-07-01 |
| Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic Keratosis (NCT03575780) | Athenex, Inc. | 2018-09-07 |
| The Study of Plum-blossom Needling Enhancing Efficacy of Aminolevulinic Acid-photodynamic Therapy for Actinic Keratosis (NCT03596619) | Shanghai Dermatology Hospital | 2018-08-30 |
| Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention (NCT03642535) | Shanghai Dermatology Hospital | 2018-08-30 |
| Microwave Therapy for Treatment of Precancerous Actinic Keratoses (NCT03483935) | University of Dundee | 2018-03-07 |
| Nevus Doctor Clinical Decision Support for GPs (NCT03246412) | University Hospital of North Norway | 2018-01-17 |
| Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis (NCT03826550) | Encube Ethicals Pvt. Ltd. | 2018-01-12 |
| Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia (NCT03906253) | Wright State University | 2018-01-10 |
| Daylight Photodynamic Therapy for Actinic Keratosis (NCT03322293) | University of California, San Francisco | 2017-12-01 |
| Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure (NCT03315286) | Weill Medical College of Cornell University | 2017-10-11 |
| Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents (NCT03279328) | University of Arizona | 2017-10-10 |
| A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp (NCT03285477) | Almirall, S.A. | 2017-09-18 |
| PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK (NCT03511326) | Galderma R&D | 2017-06-07 |
| Photodynamic Therapy Incubation Times for Actinic Keratosis (NCT03066843) | Northwestern University | 2017-03-01 |
| Nicotinamide for Prevention of Pre-malignant Actinic Keratosis in Kidney Transplant Recipients (NCT04843553) | Rhode Island Hospital | 2016-10-14 |
| New Treatments for Actinic Keratoses of the Scalp (NCT05456334) | Helsinki University Central Hospital | 2016-03-24 |
| Daylight-PDT With MAL for AK and Photodamaged Skin (NCT02736760) | University Hospital Regensburg | 2016-03-03 |
| Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses (NCT00756288) | Northwestern University | 2016-03-01 |
| Actinic Keratoses Treatment With Metvix® in Combination With Light (NCT02373371) | University Hospital, Limoges | 2015-03-25 |
| Treatment of Actinic Keratoses (AK) on the Face (NCT02411851) | Icahn School of Medicine at Mount Sinai | 2015-03-01 |
| A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy (NCT02451579) | Goldman, Butterwick, Fitzpatrick and Groff | 2015-02-01 |
| Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL (NCT02149342) | Joint Authority for Päijät-Häme Social and Health Care | 2014-05-01 |
| A Comparison of White-light and Daylight Topical Methyl 5-aminolaevulinic Acid Photodynamic Therapy for Actinic Keratoses (NCT02520700) | St Vincent's University Hospital, Ireland | 2013-09-01 |
| Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses (NCT01821391) | Galderma R&D | 2013-07-01 |
| Effects of Topical Diclofenac on Tumor Metabolism (NCT01935531) | University Hospital Regensburg | 2013-06-01 |
| Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Hypertrophic Actinic Keratoses (NCT02251652) | Icahn School of Medicine at Mount Sinai | 2013-04-01 |
| Continuous Quality Improvement (CQI) Pilot Study Evaluating the Utility of an Educational Video (NCT02062853) | University of California, Davis | 2012-11-01 |
| Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients (NCT01538901) | Medical University of Vienna | 2012-09-01 |
| Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses (NCT01475071) | Galderma R&D | 2012-03-01 |
| A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses (NCT01502020) | Actavis Mid-Atlantic LLC | 2011-02-01 |
| Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients (NCT01532453) | Spirig Pharma Ltd. | 2010-11-01 |
| Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and Placebo (NCT01354717) | Spear Pharmaceuticals | 2010-09-01 |
| Photodynamic Therapy With Levulan® +/- Topical Retinoid Pre-Treatment In The Treatment Of Actinic Keratoses (NCT01053000) | Stewart, Roger H., M.D., P.A. | 2010-01-01 |
| A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations (NCT00942604) | Peplin | 2009-07-01 |
| ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients (NCT00865878) | DUSA Pharmaceuticals, Inc. | 2009-05-01 |
| Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses (NCT00774787) | Rigel Dermatology | 2008-10-01 |
| The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses (NCT00786994) | Birken AG | 2008-10-01 |
| A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations (NCT00742391) | Peplin | 2008-09-01 |
| Carac & PDT Combination in the Treatment Of Actinic Keratoses (NCT06712381) | Skin Laser & Surgery Specialists | 2008-08-01 |
| A Randomized Multicenter Study of Daylight Mediated Photodynamic Therapy (PDT) (NCT00711178) | Bispebjerg Hospital | 2008-06-01 |
| Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis (NCT00948428) | Actavis Inc. | 2008-05-01 |
| Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year (NCT00668733) | Graceway Pharmaceuticals, LLC | 2008-04-01 |
| Phase II AK Study in Organ Transplant Patients (NCT00829192) | Clinuvel Pharmaceuticals Limited | 2007-11-01 |
| Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005 (NCT00544258) | Peplin | 2007-10-01 |
| A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel (NCT00427050) | Peplin | 2007-01-01 |
| Treatment of Actinic Keratoses With Photodynamic Therapy Using Sunlight Versus Red Light (NCT00432224) | Bispebjerg Hospital | 2006-05-01 |
| A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ (NCT00189254) | MEDA Pharma GmbH & Co. KG | 2005-04-01 |
| Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses (NCT00175643) | University of British Columbia | 2005-02-01 |
| An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses (NCT00377273) | Sanofi | 2003-11-01 |